Evaluate Veterans With MGUS for Cardiovascular Disease

Monoclonal gammopathy of undetermined significance (MGUS) is not considered a hematological condition of concern, yet it is associated with lower overall survival. VA researchers led by Lawrence Liu, MD, of the St. Louis VAMC, explored whether the reduced life expectancy arose from an increased risk of cardiovascular events.

GLP-1 Use Reduces Risk of MGUS Progression in Some Veterans

Glucagon-like peptide 1 (GLP-1) receptor agonists have gained huge popularity as they have demonstrated the ability to substantially reduce both blood-glucose levels and weight. In addition, recent research suggests cardiovascular and renal benefits to their use in certain populations.

Army Names Kenney and Petty Best Medics for 2023

Anyone with a 68W military occupation specialty signs up to go above and beyond the call of duty as a matter of course. As combat medic specialists, they provide life-saving treatment in the chaos and trauma of battle and accept responsibility for the health and well-being of their fellow soldiers on base.